Clinical Trial

A Study to Determine the Safety and Efficacy of NT-501 With MHFM

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated July 10, 2025 (before its estimated May 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is to determine the long-term levels of CNTF, and the clinical safety and efficacy of the NT-501 implants with the Medica Hollow Fiber Membrane (MHFM) in participants with macular telangiectasia type 2.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2024-04-29; most recent amendment 2025-07-08.
Status change: Recruiting → Active, Not Recruiting 2025-04-30
Status change: Not Yet Recruiting → Recruiting 2025-03-13
Trial Details
NCT Number NCT06397131
Lead Sponsor Neurotech Pharmaceuticals
Conditions Macular Telangiectasia Type 2
Enrollment 12 participants
Start Date 2025-03-06
Primary Completion 2026-05-01 (estimated)
Study Completion 2026-07-24 (estimated)
Updated on ClinicalTrials.gov 2025-07-10